lunes, 31 de marzo de 2014

Annals of Internal Medicine | Screening for Cognitive Impairment in Older Adults: U.S. Preventive Services Task Force Recommendation Statement

Annals of Internal Medicine | Screening for Cognitive Impairment in Older Adults: U.S. Preventive Services Task Force Recommendation Statement



Clinical Guidelines |

Screening for Cognitive Impairment in Older Adults: U.S. Preventive Services Task Force Recommendation Statement FREE ONLINE FIRST

Virginia A. Moyer, MD, MPH, on behalf of the U.S. Preventive Services Task Force*
Ann Intern Med. Published online 25 March 2014 doi:10.7326/M14-0496
Text Size: A A A
Description: Update of the 2003 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for dementia.
Methods: The USPSTF reviewed the evidence on the benefits, harms, and sensitivity and specificity of screening instruments for cognitive impairment in older adults and the benefits and harms of commonly used treatment and management options for older adults with mild cognitive impairment or early dementia and their caregivers.
Population: This recommendation applies to universal screening with formal screening instruments in community-dwelling adults in the general primary care population who are older than 65 years and have no signs or symptoms of cognitive impairment.
Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for cognitive impairment. (I statement)

The U.S. Preventive Services Task Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients without related signs or symptoms.
It bases its recommendations on the evidence of both the benefits and harms of the service and an assessment of the balance. The USPSTF does not consider the costs of providing a service in this assessment.
The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision making to the specific patient or situation. Similarly, the USPSTF notes that policy and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms.
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for cognitive impairment. (I statement)
See the Clinical Considerations section for suggestions for practice regarding the I statement.
See the Figure for a summary of the recommendation and suggestions for clinical practice.
Figure.
Screening for cognitive impairment in older adults: clinical summary of U.S. Preventive Services Task Force recommendation.
Appendix Table 1 describes the USPSTF grades, and Appendix Table 2 describes the USPSTF classification of levels of certainty regarding net benefit.
Appendix Table 1. What the USPSTF Grades Mean and Suggestions for Practice 
Appendix Table 2. USPSTF Levels of Certainty Regarding Net Benefit 

No hay comentarios:

Publicar un comentario